- Duane Morris partner John Maher doffing civilian hat, donning Kevlar helmet
- Former General Counsel of the U.S. Office of Personnel Management John Maher Rejoins Duane Morris
- Duane Morris' Boston Office Adds IP Partner Vincent Capuano, Ph.D.
- Duane Morris Of Counsel Arthur Dresner to Speak at the Center for Business Intelligence's 2nd Annual Pharmaceutical Congress on Paragraph IV Disputes and Settlements
- Duane Morris Partner Terry Gaffney to Speak at FDA Boot Camp
- Duane Morris Attorneys to Speak at PBI's Third Annual Intellectual Property Law Institute
- FDA to Increase Criminal Prosecution of Corporate Officials in the Pharmaceutical Industry
- FDA Issues Draft Guidance Regarding the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications
- Federal Preemption of Failure to Warn Claims Against Generic Drug Companies
Intellectual Property: Generic Pharmaceuticals
Duane Morris lawyers have significant experience with the complexities involved in bringing generic pharmaceuticals to market. Our lawyers' and registered patent agents' experience involves biotechnology processes and products, chemical processes, synthesis and products, medical devices, formulations, experiments and polymorphic products to name a few.
Attorneys at Duane Morris specialize in the representation of worldwide generic pharmaceutical companies in their quest to enter the U.S. market with new products. We have significant experience in representing clients in litigation related to abbreviated new drug applications (ANDAs) filed under the Hatch-Waxman law, as well as generation of non-infringement, invalidity and freedom-to-operate opinions with respect to patents listed in the Orange Book.
Duane Morris also coordinates with international networks of law firms to secure and maintain patent protection throughout the world. The firm's Intellectual Property attorneys thoroughly grasp the science and technology behind each client's ideas. All of the firm's patent lawyers and agents have science or engineering backgrounds, many with advanced degrees, and most have significant industry experience in their respective disciplines, including:
- Advanced materials
- Biochemistry
- Biotechnology
- Medical and mechanical devices
- Medicine
- Pharmaceuticals
- Abbreviated New Drug Application (ANDA) and related litigation
- Medicinal chemistry
- Small molecule chemistry
- Combinatorial chemistry
- Formulations
- Organic chemistry/synthetic pathways
When our IP attorneys enter a courtroom, they are adept at explaining complex technical issues in a straightforward manner and presenting our client's story to the judge and jurors in the most compelling way possible. We handle patent litigation for large and small corporations as well as individual inventors and start-up enterprises. We also are experienced in conducting interference proceedings before the U.S. Patent and Trademark Office.
We help our clients in understanding how to maximize the value of patents and we appreciate the importance of carefully managing and implementing patent portfolios for the benefit of their businesses. We offer our clients technology solutions for real-time patent docket management through the Duane Morris IP Portal, giving clients anytime/anywhere access to information on their IP holdings, including status updates on filings and alerts to upcoming deadlines. Also, our IP Practice Group has substantial experience in the domestic and international licensing and transfer of all forms of intellectual property, including patents, trademarks, copyrights and trade secrets.
For Additional Information
For more information, please contact Lewis F. Gould, Jr. or any of the lawyers referenced in the Attorney Listing.
